3,881
Views
46
CrossRef citations to date
0
Altmetric
Brief Report

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO

, , , , , , , , , , , , , , , & show all
Pages 55-61 | Received 17 Aug 2017, Accepted 30 Oct 2017, Published online: 05 Dec 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.